A Danish drugmaker has revealed a stunning increase in pollution amid plans to boost production of its popular weight loss ...

Foundation is proud to announce a $2 million donation from Novo Nordisk Canada Inc. to support the establishment of the Metabolic Centre of Excellence at the MUHC. This contribution will help position ...

With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic ...

Awakened Films, New Jersey's trusted name in cinematic video production and a woman-owned business, is proud to announce its expansion into social media marketing, officially positioning itself as a ...

That being acknowledged, we’re here with a list of the 12 best German stocks to buy according to hedge funds.

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter for marketing and ... GSK, and Novo Nordisk. On 14 November, Eli Lilly ...

Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Pharmaceutical giant Novo Nordisk (NYSE: NVO) built its business on insulin and has emerged as a leading innovator in GLP-1 agonists, relatively new drugs that treat obesity and type 2 diabetes by ...

GDANSK/LONDON, March 28 (Reuters) - Bank of America analysts on Friday said Novo Nordisk (NOVOb.CO), opens new tab may miss first-quarter expectations, as sales of its blockbuster Wegovy and ...

There is a long-running health crisis impacting the modern world. According to the World Health Organization, one in eight people worldwide were living with obesity as of 2022. Obesity causes ...

Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to LX9851, an experimental oral treatment for obesity and related metabolic disorders.